High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial

BACKGROUND: The efficacy and safety of high flow nasal therapy (HFNT) in patients with acute hypercapnic exacerbation of chronic obstructive pulmonary disease (AECOPD) are unclear. Our aim was to evaluate the short-term effect of HFNT versus NIV in patients with mild-to-moderate AECOPD, with the hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortegiani, Andrea, Longhini, Federico, Madotto, Fabiana, Groff, Paolo, Scala, Raffaele, Crimi, Claudia, Carlucci, Annalisa, Bruni, Andrea, Garofalo, Eugenio, Raineri, Santi Maurizio, Tonelli, Roberto, Comellini, Vittoria, Lupia, Enrico, Vetrugno, Luigi, Clini, Enrico, Giarratano, Antonino, Nava, Stefano, Navalesi, Paolo, Gregoretti, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734463/
https://www.ncbi.nlm.nih.gov/pubmed/33317579
http://dx.doi.org/10.1186/s13054-020-03409-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734463/
https://www.ncbi.nlm.nih.gov/pubmed/33317579
http://dx.doi.org/10.1186/s13054-020-03409-0

Ejemplares similares